Contact
Please use this form to send email to PR contact of this press release:
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
TO:
Please use this form to send email to PR contact of this press release:
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
TO: